Found: 18
Select item for more details and to access through your institution.
Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021–April 2022.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 1, p. 1, doi. 10.1093/ofid/ofac698
- By:
- Publication type:
- Article
High prevalence of fluoroquinolone‐resistant UTI among US emergency department patients diagnosed with urinary tract infection, 2018–2020.
- Published in:
- Academic Emergency Medicine, 2022, v. 29, n. 9, p. 1096, doi. 10.1111/acem.14545
- By:
- Publication type:
- Article
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years -- IVY Network, 18 States, September 8-November 30, 2022.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2022, v. 71, n. 51/52, p. 1625, doi. 10.15585/mmwr.mm715152e2
- By:
- Publication type:
- Article
Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December 26, 2021-August 31, 2022.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2022, v. 71, n. 42, p. 1327, doi. 10.15585/mmwr.mm7142a3
- By:
- Publication type:
- Article
Effectiveness of mRNA Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death - United States, March 2021-January 2022.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2022, v. 71, n. 12, p. 459
- By:
- Publication type:
- Article
Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults -- United States, August-December 2021.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2022, v. 71, n. 4, p. 118
- By:
- Publication type:
- Article
Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions -- United States, March-August 2021.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2021, v. 70, n. 38, p. 1337, doi. 10.15585/mmwr.mm7038e1
- By:
- Publication type:
- Article
Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults - United States, March-July 2021.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Utilization of anti–factor Xa levels to guide reversal of oral factor Xa inhibitors in the emergency department.
- Published in:
- American Journal of Health-System Pharmacy, 2022, v. 79, n. 1, p. e20, doi. 10.1093/ajhp/zxab326
- By:
- Publication type:
- Article
Airway management team for patients with COVID-19: A new role for emergency medicine pharmacists.
- Published in:
- American Journal of Health-System Pharmacy, 2020, v. 77, n. 14, p. 1102, doi. 10.1093/ajhp/zxaa129
- By:
- Publication type:
- Article
Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines for Preventing Coronavirus Disease 2019 Hospitalizations in the United States.
- Published in:
- Clinical Infectious Diseases, 2022, v. 74, n. 9, p. 1515, doi. 10.1093/cid/ciab687
- By:
- Publication type:
- Article
Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.
- Published in:
- JAMA: Journal of the American Medical Association, 2021, v. 326, n. 20, p. 2043, doi. 10.1001/jama.2021.19499
- By:
- Publication type:
- Article
Protection of Messenger RNA Vaccines Against Hospitalized Coronavirus Disease 2019 in Adults Over the First Year Following Authorization in the United States.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 3, p. e460, doi. 10.1093/cid/ciac381
- By:
- Publication type:
- Article
Effectiveness of the Ad26.COV2.S (Johnson & Johnson) Coronavirus Disease 2019 (COVID-19) Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, p. S159, doi. 10.1093/cid/ciac439
- By:
- Publication type:
- Article
Intravenous Antibiotic Susceptibility for Urinary Tract Infection Prior to Emergency Department Discharge.
- Published in:
- Hospital Pharmacy, 2021, v. 56, n. 5, p. 513, doi. 10.1177/0018578720925386
- By:
- Publication type:
- Article
mRNA Vaccine Effectiveness Against Coronavirus Disease 2019 Hospitalization Among Solid Organ Transplant Recipients.
- Published in:
- Journal of Infectious Diseases, 2022, v. 226, n. 5, p. 797, doi. 10.1093/infdis/jiac118
- By:
- Publication type:
- Article
Effectiveness of mRNA Vaccines Against COVID-19 Hospitalization by Age and Chronic Medical Conditions Burden Among Immunocompetent US Adults, March-August 2021.
- Published in:
- Journal of Infectious Diseases, 2022, v. 225, n. 10, p. 1694, doi. 10.1093/infdis/jiab619
- By:
- Publication type:
- Article
Empirical antimicrobial prescribing for pyelonephritis in patients discharged from 15 US Emergency Departments: an opportunity for improvement.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 5, p. 1038, doi. 10.1093/jac/dkae070
- By:
- Publication type:
- Article